Key result
Apixaban is recommended by the National Institute for Health and Care Excellence as a treatment option for deep vein thrombosis and pulmonary embolism.
Answers are grounded in this paper and cite their sources.
Highlights recent NICE guidance recommending apixaban for the treatment of VTE.
Belinda Linden examines recent guidance from the National Institute for Health and Care Excellence (NICE), published last month, recommending apixaban as an option for the treatment of deep vein thrombosis and pulmonary embolism
No takes yet. Share an insight, caveat, or question.
Belinda Linden (2015) studied this question. Apixaban is recommended by the National Institute for Health and Care Excellence as a treatment option for deep vein thrombosis and pulmonary embolism.
Synapse has enriched 10 related papers. Consider them for comparative context: